Clinmark
Smart Global Clinical Trails

Successful clinical trial execution is built on the pillars of strategic planning, precise scheduling, and informed identification of countries and sites for trials. To meet these conditions, companies conducting clinical research rely on CROs with expertise in a given study’s phases. Flourishing in this competitive arena, Clinmark has curated its role as an experienced CRO by combining professional consulting, execution and education in clinical research. The company offers full-scale global clinical trial services to pharmaceutical and biotechnological companies and possesses a scientific outlook in their philosophy and business activities. Clinmark advises and directs midsize and small biotech companies and startups through the necessary steps about their product development. While adopting a close partnership model, Clinmark encourages clients’ involvement in every step of the project. The company takes the initiative in clinical consulting and leads in the planning, organizing, and managing of clinical trial studies from phases I – IV.

“Our effective methodology of setting up clinical trial projects globally enables us to accomplish any form of a project within a very short time,” says Marek Wasiluk, CEO of Clinmark.



Since its inception in 2001, Clinmark has gained considerable acclaim for ensuring flexibility, commitment, and high-quality standards in project execution. The combination of open mindedness and rich experience enables Clinmark to take out-of-the-box decisions in many challenging projects. It offers high-end services in compliance with European Medicines Agency (EMA) and FDA guidelines, ISO Standards, Good Clinical Practices, and Standard Operating Procedures (SOP). Clinmark’s organizational structure facilitates them with an effective way of setting up projects globally.

The company follows preventive practices such as conducting audits or assessments in the early stage of a project to mitigate risks. By implementing corrective and preventive actions (CAPA) at every step, which act as an insurance policy for Sponsors, Clinmark provides cost-effective and customized solutions to various, therapeutic research studies.

Clinmark’s assistance encourages companies to expand into unknown regions or sites. The company helps clients make informed decisions around strategizing and implementing expansion plans, minimizing risk.

From protocol writing through data monitoring, medical monitoring, project management, and final report preparation, Clinmark provides customers with a complete medical products and medical device trial package. It offers a full range of pre-clinical services covering pharmacological, toxicological, and other tests according to the type of product and client requirements. As a first step, Clinmark internally discusses and analyzes every project with its client to understand their expectations, problems, and needs. After collating study data, Clinmark’s team of biostatisticians, data managers, medical experts, and medical writers analyze the data and process the study results. The company ensures a strong setup for any project by identifying potential risks and the solutions to mitigate them. It also develops a Clinical Study Report describing the protocol execution and the conclusions of the product development process.

Our effective methodology of setting up clinical trial projects globally enables us to accomplish any form of a project very fast and our flexibility and individual approach to each study ensures its successful completion

Clinmark’s consulting department supports clients in the early stages of product development by providing an optimal regulatory path and creating product development plans for drugs and medical devices. Clinmark’s team has broad experience in preparing and planning every CE Marking Regulatory Process stage to MDR and FDA requirements. The company’s experts assist the customers in the conformity assessment of a medical device in cooperation with authoritative bodies. Before business mergers or acquisitions, Clinmark thoroughly assesses the client company. A thorough evaluation and analysis of the company’s research pipeline, know-how, and operational performance are essential to the due diligence audit.

Over the years, Clinmark has helped many clients with personalized solutions for clinical development. For instance, it assisted one of its clients with a study on orphan diseases, where the client was having difficulty in finding a suitable site and recruiting subjects for years. Clinmark stepped in and found few sites, acquired regulatory approvals, and recruited subjects within three months. This allowed the client to accelerate their study and create cost-effective solutions.

With unique consulting skills developed and practiced for several years in more than 400 consulting and audit projects in nearly 75 countries, Clinmark is an expert in optimizing clinical research. The company combines operational activity in clinical research, professional consulting, and education, creating a synergy that provides quantifiable advantages to the client in their clinical research processes.